HIGH-DOSE METOCLOPRAMIDE AND DEXAMETHASONE AS AN ANTIEMETIC IN OUTPATIENTS RECEIVING CHEMOTHERAPY FOR BREAST-CANCER - 2ND STUDY

被引：13

作者：

GEZ, E

WARNEREFRATY, E

BENYOSEF, R

BENBARUCH, N

YITZHAKI, N

UZIELY, B

BRUFMAN, G

BIRAN, S

机构：

来源：

ONCOLOGY | 1987年 / 44卷 / 04期

关键词：

D O I：

10.1159/000226485

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：237 / 239

页数：3

共 16 条

[1] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].

AAPRO, MS ;

PLEZIA, PM ;

ALBERTS, DS ;

GRAHAM, V ;

JONES, SE ;

SURWIT, EA ;

MOON, TE .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471

[2]

BRUERA ED, 1983, CANCER TREAT REP, V67, P381

[3] ANTI-EMETIC EFFICACY OF DEXAMETHASONE THERAPY IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].

CASSILETH, PA ;

LUSK, EJ ;

TORRI, S ;

DINUBILE, N ;

GERSON, SL .

ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (07) :1347-1349

[4] RANDOMIZED OPEN CROSSOVER TRIAL BETWEEN METOCLOPRAMIDE (MCP) AND DEXAMETHAZONE (DXM) FOR THE PREVENTION OF CISPLATIN-INDUCED NAUSEA AND VOMITING [J].

COGNETTI, F ;

PINNARO, P ;

CARLINI, P ;

CONTI, EM ;

CORTESE, M ;

POLLERA, CF .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (02) :183-187

[5] IMPROVED CONTROL OF CISPLATIN-INDUCED EMESIS WITH A METOCLOPRAMIDE-DEXAMETHASONE COMBINATION [J].

COGNETTI, F ;

PINNARO, P ;

CARLINI, P ;

CAPORALI, C ;

RUGGERI, EM ;

POLLERA, CF .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) :235-237

[6] METOCLOPRAMIDE IN THE REDUCTION OF NAUSEA AND VOMITING ASSOCIATED WITH COMBINED CHEMOTHERAPY [J].

COX, R ;

NEWMAN, CE ;

LEYLAND, MJ .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (01) :133-135

[7]

DAVID M, 1984, CANCER TREAT REP, V68, P921

[8] HIGH-DOSE METOCLOPRAMIDE AND DEXAMETHASONE AS AN ANTIEMETIC IN CHEMOTHERAPY OF BREAST-CANCER [J].

GEZ, E ;

GOODMAN, S ;

ISACSON, R ;

GERRA, C ;

SULKES, A .

ONCOLOGY, 1986, 43 (03) :173-175

[9] METOCLOPRAMIDE - A REVIEW OF ANTI-EMETIC TRIALS [J].

GRALLA, RJ .

DRUGS, 1983, 25 :63-73

[10]

HELLMAN S, 1982, CANCER PRINCIPLES PR, P949

← 1 2 →